Guardian Pharmacy Services, Inc.

NYSE:GRDN

Medical - Distribution

Healthcare
$48.84 +0.39%

+$0.17 today

Market cap
$3.09B
Beta
0.08
P/E (TTM)
52.0
EPS (TTM)
$0.84
52W Low $19.30High $44.00

Volume 0.45M

Average 0.48M

GRDN Other Current Assets

Current assets not reported separately, such as prepaid expenses.

Guardian Pharmacy Services, Inc.NYSE: GRDN

Other Current Assets · Q2 FY2026 · quarter ended Jun 2026

Other current assets falls 20.3% from a year ago

Other current assets stood at $10.65M at the end of Q2 FY2026, down 20.3% from a year earlier and down 6.8% from the prior quarter. Over 3 fiscal years it compounded at +2.9% a year.

Context

  • Other current assets amounted to 2.4% of total assets at the end of Q2 FY2026, down 1.3 pp from a year earlier.
  • Other current assets increased in 2 of the last 3 fiscal years.

What to watch

Whether other current assets keeps falling in the next quarterly balance sheet after a -20.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$10.65M-6.8% QoQ
Last fiscal yearDec 2025
$11.04M+14.8% YoY
Year agoJun 2025
$13.36M-20.3% since
Other Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-20.3%——
1 year+14.8%——
3-year CAGR+2.9%——
5-year CAGR——
10-year CAGR——

Other Current Assets history

USD · from the balance sheet

Latest · FY2025
11.04M USD
Year-over-year change
+14.8%
4-year CAGR
+6.7%

Other Current Assets vs competitors

How GRDN compares with its peers on the latest reported figures

  • GRDN's Jun 2026 other current assets of $10.65M is the 7th highest of the 11 companies compared; the peer median is $16.71M.
  • Its year-over-year change of -20.3% is the lowest of 10, against a peer median of +50.7%.
  • Other current assets amounts to 2.4% of total assets for GRDN, versus a peer median of 1.7%.
GRDN Competitors Peer median
Other Current Assets for GRDN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
QDELQuidelOrtho CorporationMar 2026$82.3M +50.7%—1.5%
NHCNational HealthCare CorporationSep 2026$55.28M +10.6%—2.7%
TWSTTwist Bioscience CorporationSep 2026$38.71M +13004.0%+48.9%3.5%
EWTXEdgewise Therapeutics, Inc.Sep 2026$28.58M +170.6%—1.6%
TXG10x Genomics, Inc.Sep 2026$19.57M +1.9%+5.0%1.8%
NUVBNuvation Bio Inc.Jun 2026$13.86M +67.9%+44.6%1.9%
GRDNGuardian Pharmacy Services, Inc.Jun 2026$10.65M -20.3%+2.9%2.4%
MDPediatrix Medical Group, Inc.Sep 2026$8.96M -12.3%-12.5%0.4%
PRCTPROCEPT BioRobotics CorporationMar 2026$8.47M +11.9%+16.0%1.7%
MESOMesoblast LimitedJun 2026$1.03M +160.8%+418.6%0.1%
JANXJanux Therapeutics, Inc.Mar 2026$0 ——0.0%
Peer median (excluding GRDN) $16.71M+50.7%+30.3%1.7%

Competitors are the stored peer set for GRDN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents15.01M607K752K4.66M65.62M
Short-term Investments00000
Net Receivables55.25M67.83M77.26M97.15M101.61M
Inventory33.09M41.44M36.73M40.55M43.36M
Other Current Assets8.52M10.12M14.86M9.62M11.04M
Total Current Assets111.87M120M129.6M151.99M221.63M
Property, Plant & Equipment (Net)51.72M65.19M73.18M78.96M90.17M
Goodwill54.63M56.05M56.05M69.3M79.74M
Intangible Assets17.09M14.44M11.98M14.91M18.48M
Long-term Investments00000
Tax Assets0005.27M2.2M
Other Non-current Assets529K435K358K383K436K
Total Non-current Assets123.98M136.12M141.56M168.83M191.02M
Total Assets235.85M256.11M271.17M320.81M412.66M
Account Payables64.62M78.1M85.6M102.42M116.21M
Short-term Debt3.71M7.96M12.98M00
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities20.42M3.62M12.33M34.87M37.35M
Total Current Liabilities111.54M112.01M138.02M144.12M160.7M
Long-term Debt26.99M22.97M18.99M00
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities27.88M21.54M27.26M3.42M4.04M
Total Non-current Liabilities70.99M68.18M73.29M26.71M34.03M
Total Liabilities182.53M180.18M211.31M170.83M194.73M
Common Stock24.11M42.73M28.21M63K63K
Retained Earnings00017.12M66.34M
Accumulated OCI(185K)0000
Other Stockholders Equity00000
Minority Interest29.39M33.2M31.65M7.31M12.17M
Total Equity53.32M75.93M59.86M149.98M217.92M
Total Debt55.04M62.98M69.15M30.13M37.14M
Net Debt40.03M62.38M68.4M25.47M(28.48M)

Guardian Pharmacy Services, Inc.

NYSE:GRDN

Intrinsic Alpha fair value

Locked

Current Price

$48.84

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.